Immune Design Corp. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Immune Design Corp. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $228.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2019-03-13
- Immune Design Corp. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $286.00K.
- Immune Design Corp. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-12-31 was -$494.00K, a 631.18% decline year-over-year.
- Immune Design Corp. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-09-30 was $30.85M, a 15800.52% increase year-over-year.
- Immune Design Corp. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-06-30 was $101.00K, a 99.87% decline year-over-year.
- Immune Design Corp. net cash provided by (used in) financing activities, continuing operations for fiscal 2018 was $228.00K, a 99.74% decline from fiscal 2017.
- Immune Design Corp. net cash provided by (used in) financing activities, continuing operations for fiscal 2017 was $87.34M, a 186.79% increase from fiscal 2016.
- Immune Design Corp. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $30.45M, a 59.82% decline from fiscal 2015.
- Immune Design Corp. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $75.80M, a 14.88% increase from fiscal 2014.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-12-31 | $228.00K 10-K · filed 2019-03-13 | |||
| 2017-12-31 | $87.34M 10-K · filed 2019-03-13 | |||
| 2017-03-31 | $286.00K 10-Q · filed 2017-05-04 | -$208.00K derived: sum of 2 quarters · filed 2019-03-13 | $30.64M derived: sum of 3 quarters · filed 2019-03-13 | $30.74M derived: sum of 4 quarters · filed 2019-03-13 |
| 2016-12-31 | -$494.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $30.35M derived: sum of 2 quarters · filed 2019-03-13 | $30.45M derived: sum of 3 quarters · filed 2019-03-13 | $30.45M 10-K · filed 2019-03-13 |
| 2016-09-30 | $30.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $30.95M derived: sum of 2 quarters · filed 2016-11-09 | $30.95M 10-Q · filed 2016-11-09 | $31.04M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $101.00K 10-Q · filed 2016-08-09 | $194.00K derived: sum of 3 quarters · filed 2018-03-14 | $388.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | $93.00K derived: sum of 2 quarters · filed 2018-03-14 | $287.00K derived: sum of 3 quarters · filed 2018-03-14 | $75.85M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $287.00K derived: sum of 2 quarters · filed 2018-03-14 | $75.85M derived: sum of 3 quarters · filed 2018-03-14 | $75.80M 10-K · filed 2018-03-14 |
| 2015-09-30 | $194.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $75.75M derived: sum of 2 quarters · filed 2016-11-09 | $75.70M 10-Q · filed 2016-11-09 | $75.71M derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-06-30 | $75.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $75.51M 10-Q · filed 2016-08-09 | $75.51M derived: sum of 3 quarters · filed 2017-03-07 | $142.86M derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-03-31 | -$51.00K 10-Q · filed 2016-05-10 | -$47.00K derived: sum of 2 quarters · filed 2017-03-07 | $67.30M derived: sum of 3 quarters · filed 2017-03-07 | $66.10M derived: sum of 4 quarters · filed 2017-03-07 |
| 2014-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $67.35M derived: sum of 2 quarters · filed 2017-03-07 | $66.15M derived: sum of 3 quarters · filed 2017-03-07 | $65.98M 10-K · filed 2017-03-07 |
| 2014-09-30 | $67.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $66.15M derived: sum of 2 quarters · filed 2015-11-12 | $65.98M 10-Q · filed 2015-11-12 | $98.03M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$1.37M 10-Q · filed 2015-08-12 | $30.68M derived: sum of 3 quarters · filed 2016-03-15 | $30.68M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | -$171.00K 10-Q · filed 2015-05-14 | $31.88M derived: sum of 2 quarters · filed 2016-03-15 | $31.88M derived: sum of 3 quarters · filed 2016-03-15 | |
| 2013-12-31 | $32.05M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $32.05M derived: sum of 2 quarters · filed 2016-03-15 | $32.05M 10-K · filed 2016-03-15 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $6.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $6.00K 10-Q · filed 2014-09-08 | |||
| 2012-12-31 | $10.63M 10-K · filed 2015-03-31 |